Cns (original) (raw)
Latest News for: cns
Bayer’s AMBELVIST® (gadoquatrane) Receives FDA Approval for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity in the Central Nervous System and Non-CNS Body Regions (Bayer AG)
Public Technologies 15 Jun 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 132463416) .
Paragon Advances Registration-Ready CNS Asset Addressing Important Unmet Need and Closes Sale to Teva Pharmaceutical
Business Wire 12 Jun 2026
CHICAGO--(BUSINESS WIRE)--Paragon Biosciences today announced the closing of the sale of Emalex ...
LG CNS, LX Pantos partner on humanoid-powered smart logistics
Korea Times 11 Jun 2026
LG CNS is teaming up with LX Pantos to pilot humanoid-driven automation in logistics operations, marking a step toward next-generation smart warehouses.
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
Nasdaq Globe Newswire 11 Jun 2026
Quirk’s deep expertise in CNS translational science, neuroactive steroid biology, and clinical development will be ...
Verge Labs and Tenacia Biotechnology Partner to Advance Tenacia's CNS Pipeline Using Human Data
Albany Democrat Herald 10 Jun 2026
First partnership announced under Verge Labs' platform-first model; Tenacia will apply Verge's AI platform and proprietary multimodal human tissue data to characterize targets across select CNS programs ....
Enveric Biosciences to Participate in the UBS 3rd Virtual CNS Day
Times Argus 09 Jun 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun 9, 2026-- ....
LG CNS expands AI transformation biz through adoption of Anthropic’s Claude
Korea Times 09 Jun 2026
Technology services provider LG CNS said Tuesday it ... LG CNS said the partnership is intended to support AI-driven productivity improvements and expand the use of generative AI in corporate operations.
LG CNS Hosts "Optimization Grand Challenge 2026" to Tackle Real-World Industrial Challenges Using Mathematics
PR Newswire 09 Jun 2026
SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- LG CNS, a leading AX (AI Transformation) company in Korea, is set to host the Optimization Grand Challenge 2026 (OGC 2026), a global mathematics optimization competition ... About LG CNS ... SOURCE LG CNS.
Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
PR Newswire 09 Jun 2026
BLKR201 / LNK01006 is a novel, selective CNS-penetrant allosteric TYK2 inhibitor designed to regulate immune signaling within the central nervous system. TYK2 is a validated target, and the CNS ...
LG CNS launches agentic AI platform for large-scale system development
Korea Times 08 Jun 2026
LG CNS unveiled an agentic artificial intelligence (AI)-powered development platform designed to automate the entire cycle of large-scale enterprise IT systems, the company said Monday.
CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This ...
ACCESSWIRE 08 Jun 2026
HOUSTON, TX / ACCESS Newswire / June 8, 2026 / CNS Pharmaceuticals, Inc ... About CNS Pharmaceuticals, Inc. CNS Pharmaceuticals is a biotechnology company focused on developing innovative therapies for serious diseases ... CNS Pharmaceuticals, Inc.
Gene and Cell Therapies Targeting CNS Disorders Market Expected to Experience Accelerated Growth and Market ...
GetNews 05 Jun 2026
Get a Free sample for the Gene and Cell Therapies Targeting CNS Disorders Market Report.. Some of the key facts of the Gene and Cell Therapies Targeting CNS Disorders Market Report. ... Key Gene and Cell Therapies Targeting CNS Disorders Companies.
West Genesee girls lacrosse star’s game-winner seals revenge in Class A section final rematch with CNS
The Post-Standard 03 Jun 2026
Cortland, N.Y. — West Genesee’s savior in the Section III Class A final is exactly who the Wildcats would expect to deliver in the biggest moment ....
The East Tennessee Foundation and CNS Y-12 Community Investment Fund announce grant opportunity
The Newport Plain Talk 03 Jun 2026
KNOXVILLE — The East Tennessee Foundation (ETF/Foundation) is now accepting applications for the 2026 CNS Y-12 Community Investment Fund grant cycle. Applications opened May 15 and will close on June 11, 2026, at 5.00 p.m. Eastern ....
CRC CEO Tom Zoda, Ph.D., Chairs ASCP 2026 Panel on Preventable Failure Risk in CNS Clinical Trials
PR Newswire 03 Jun 2026
Discussion explored how study execution and operational decision-making can influence interpretability in CNS clinical research ... failure risk in central nervous system (CNS) clinical trials.